Summary

Market Definition and Overview
The Global Biofabrication Market is valued at approximately USD 2.62 billion in 2024 and is anticipated to witness a remarkable CAGR of 28.30% over the forecast period 2025-2035. Biofabrication encompasses advanced technologies and processes that enable the creation of complex tissue constructs and organ-like structures, primarily using 3D-bioprinting and tissue engineering techniques. These innovative solutions are employed across regenerative medicine, pharmaceutical research, and disease modeling, offering transformative capabilities in personalized healthcare and organ transplantation. The growth trajectory of the market is propelled by rising investments in regenerative medicine, increasing prevalence of chronic diseases, and the urgent need to address organ donor shortages. Continuous technological breakthroughs and the integration of novel biomaterials further amplify market opportunities.
The escalating focus on personalized medicine and tissue regeneration has significantly fueled the adoption of biofabrication technologies. As hospitals, research institutions, and pharmaceutical companies strive for scalable and reproducible tissue constructs, the demand for sophisticated 3D-bioprinting platforms and tissue engineering solutions has surged. According to global health reports, organ failure and tissue degeneration remain major healthcare challenges, emphasizing the importance of biofabrication for creating functional tissue substitutes. Moreover, the development of hybrid biomaterials and bio-inks has expanded the scope of applications, including drug testing, disease modeling, and regenerative therapies. However, high capital requirements and regulatory complexities pose potential challenges to widespread adoption during the forecast period 2025-2035.

The detailed segments and sub-segments included in the report are:
By Technology:
- 3D-Bioprinting
- Tissue Engineering
By Material Type:
- Natural Biomaterials
- Synthetic Biomaterials
- Hybrid Materials
By Application:
- Regenerative Medicine
- Drug Discovery & Testing
- Tissue & Organ Modeling
By Region:
North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Spain
- Italy
- RoE
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
Latin America
- Brazil
- Mexico
Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa

3D-Bioprinting Segment Expected to Dominate the Market
The 3D-bioprinting segment is expected to dominate the biofabrication market owing to its precision, scalability, and ability to fabricate patient-specific tissue constructs. The segment’s dominance is underpinned by growing demand for organ-on-chip models, regenerative therapies, and high-throughput drug screening platforms. Tissue engineering, although steadily gaining momentum for its potential in complex tissue regeneration and scaffold-based therapies, is projected to experience moderate growth relative to 3D-bioprinting applications.
Natural Biomaterials Lead in Revenue Contribution
In terms of material type, natural biomaterials currently hold the largest revenue share, largely due to their superior biocompatibility and extensive use in regenerative medicine. Synthetic and hybrid materials are witnessing rapid adoption, driven by their tunable properties, structural stability, and compatibility with advanced 3D-bioprinting systems. This creates a nuanced market landscape where natural materials maintain widespread utilization while synthetic and hybrid materials accelerate in growth due to performance-driven applications and ongoing innovation.
North America accounted for the largest share of the biofabrication market in 2025, benefiting from well-established healthcare infrastructure, advanced R&D facilities, and substantial investment in regenerative medicine. Europe closely follows, supported by government initiatives, clinical adoption, and regulatory frameworks favoring tissue engineering and biofabrication technologies. Asia Pacific is projected to exhibit the fastest growth during the forecast period, fueled by expanding research funding, rising healthcare awareness, and a growing biotechnology sector in countries such as China and India. Latin America and the Middle East & Africa are emerging markets, driven by increasing adoption of biofabrication for clinical and pharmaceutical applications.

Major market players included in this report are:
- Organovo Holdings, Inc.
- CELLINK (BICO Group)
- 3D Bioprinting Solutions
- Cyfuse Biomedical K.K.
- Aspect Biosystems
- Allevi (now part of 3D Systems)
- RegenHU Ltd.
- InvivoSciences
- BioBots (now part of 3D Systems)
- Poietis
- Advanced Solutions Life Sciences
- EnvisionTEC (now part of Desktop Metal)
- CollPlant Holdings Ltd.
- BioFabUSA
- Prellis Biologics

Global Biofabrication Market Report Scope:
- Historical Data - 2023, 2024
- Base Year for Estimation - 2024
- Forecast period - 2025-2035
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent to up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained above.

Key Takeaways:
- Market Estimates & Forecast for 10 years from 2025 to 2035.
- Annualized revenues and regional-level analysis for each market segment.
- Detailed analysis of the geographical landscape with country-level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of the competitive structure of the market.
- Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Global Biofabrication Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study

Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. key Findings

Chapter 3. Global Biofabrication Market Forces Analysis
3.1. Market Forces Shaping The Global Biofabrication Market (2024-2035)
3.2. Drivers
3.2.1. rising investments in regenerative medicine
3.2.2. increasing prevalence of chronic diseases
3.3. Restraints
3.3.1. high capital requirements and regulatory complexities
3.4. Opportunities
3.4.1. Continuous technological breakthroughs and the integration of novel biomaterials

Chapter 4. Global Biofabrication Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024-2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024-2025)
4.7. Global Pricing Analysis And Trends 2025
4.8. Analyst Recommendation & Conclusion

Chapter 5. Global Biofabrication Market Size & Forecasts by Technology 2025-2035
5.1. Market Overview
5.2. Global Biofabrication Market Performance - Potential Analysis (2025)
5.3. 3D-Bioprinting
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.3.2. Market size analysis, by region, 2025-2035
5.4. Tissue Engineering
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
5.4.2. Market size analysis, by region, 2025-2035

Chapter 6. Global Biofabrication Market Size & Forecasts by Material Type 2025-2035
6.1. Market Overview
6.2. Global Biofabrication Market Performance - Potential Analysis (2025)
6.3. Natural Biomaterials
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.3.2. Market size analysis, by region, 2025-2035
6.4. Synthetic Biomaterials
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.4.2. Market size analysis, by region, 2025-2035
6.5. Hybrid Materials
6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
6.5.2. Market size analysis, by region, 2025-2035
Chapter 7. Global Biofabrication Market Size & Forecasts by Application 2025–2035
7.1. Market Overview
7.2. Global Biofabrication Market Performance - Potential Analysis (2025)
7.3. Regenerative Medicine
7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.3.2. Market size analysis, by region, 2025-2035
7.4. Drug Discovery & Testing
7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.4.2. Market size analysis, by region, 2025-2035
7.5. Tissue & Organ Modeling
7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
7.5.2. Market size analysis, by region, 2025-2035

Chapter 8. Global Biofabrication Market Size & Forecasts by Region 2025–2035
8.1. Growth Biofabrication Market, Regional Market Snapshot
8.2. Top Leading & Emerging Countries
8.3. North America Biofabrication Market
8.3.1. U.S. Biofabrication Market
8.3.1.1. Technology breakdown size & forecasts, 2025-2035
8.3.1.2. Material type breakdown size & forecasts, 2025-2035
8.3.1.3. Application breakdown size & forecasts, 2025-2035
8.3.2. Canada Biofabrication Market
8.3.2.1. Technology breakdown size & forecasts, 2025-2035
8.3.2.2. Material type breakdown size & forecasts, 2025-2035
8.3.2.3. Application breakdown size & forecasts, 2025-2035
8.4. Europe Biofabrication Market
8.4.1. UK Biofabrication Market
8.4.1.1. Technology breakdown size & forecasts, 2025-2035
8.4.1.2. Material type breakdown size & forecasts, 2025-2035
8.4.1.3. Application breakdown size & forecasts, 2025-2035
8.4.2. Germany Biofabrication Market
8.4.2.1. Technology breakdown size & forecasts, 2025-2035
8.4.2.2. Material type breakdown size & forecasts, 2025-2035
8.4.2.3. Application breakdown size & forecasts, 2025-2035
8.4.3. France Biofabrication Market
8.4.3.1. Technology breakdown size & forecasts, 2025-2035
8.4.3.2. Material type breakdown size & forecasts, 2025-2035
8.4.3.3. Application breakdown size & forecasts, 2025-2035
8.4.4. Spain Biofabrication Market
8.4.4.1. Technology breakdown size & forecasts, 2025-2035
8.4.4.2. Material type breakdown size & forecasts, 2025-2035
8.4.4.3. Application breakdown size & forecasts, 2025-2035
8.4.5. Italy Biofabrication Market
8.4.5.1. Technology breakdown size & forecasts, 2025-2035
8.4.5.2. Material type breakdown size & forecasts, 2025-2035
8.4.5.3. Application breakdown size & forecasts, 2025-2035
8.4.6. Rest of Europe Biofabrication Market
8.4.6.1. Technology breakdown size & forecasts, 2025-2035
8.4.6.2. Material type breakdown size & forecasts, 2025-2035
8.4.6.3. Application breakdown size & forecasts, 2025-2035
8.5. Asia Pacific Biofabrication Market
8.5.1. China Biofabrication Market
8.5.1.1. Technology breakdown size & forecasts, 2025-2035
8.5.1.2. Material type breakdown size & forecasts, 2025-2035
8.5.1.3. Application breakdown size & forecasts, 2025-2035
8.5.2. India Biofabrication Market
8.5.2.1. Technology breakdown size & forecasts, 2025-2035
8.5.2.2. Material type breakdown size & forecasts, 2025-2035
8.5.2.3. Application breakdown size & forecasts, 2025-2035
8.5.3. Japan Biofabrication Market
8.5.3.1. Technology breakdown size & forecasts, 2025-2035
8.5.3.2. Material type breakdown size & forecasts, 2025-2035
8.5.3.3. Application breakdown size & forecasts, 2025-2035
8.5.4. Australia Biofabrication Market
8.5.4.1. Technology breakdown size & forecasts, 2025-2035
8.5.4.2. Material type breakdown size & forecasts, 2025-2035
8.5.4.3. Application breakdown size & forecasts, 2025-2035
8.5.5. South Korea Biofabrication Market
8.5.5.1. Technology breakdown size & forecasts, 2025-2035
8.5.5.2. Material type breakdown size & forecasts, 2025-2035
8.5.5.3. Application breakdown size & forecasts, 2025-2035
8.5.6. Rest of APAC Biofabrication Market
8.5.6.1. Technology breakdown size & forecasts, 2025-2035
8.5.6.2. Material type breakdown size & forecasts, 2025-2035
8.5.6.3. Application breakdown size & forecasts, 2025-2035
8.6. Latin America Biofabrication Market
8.6.1. Brazil Biofabrication Market
8.6.1.1. Technology breakdown size & forecasts, 2025-2035
8.6.1.2. Material type breakdown size & forecasts, 2025-2035
8.6.1.3. Application breakdown size & forecasts, 2025-2035
8.6.2. Mexico Biofabrication Market
8.6.2.1. Technology breakdown size & forecasts, 2025-2035
8.6.2.2. Material type breakdown size & forecasts, 2025-2035
8.6.2.3. Application breakdown size & forecasts, 2025-2035
8.7. Middle East and Africa Biofabrication Market
8.7.1. UAE Biofabrication Market
8.7.1.1. Technology breakdown size & forecasts, 2025-2035
8.7.1.2. Material type breakdown size & forecasts, 2025-2035
8.7.1.3. Application breakdown size & forecasts, 2025-2035
8.7.2. Saudi Arabia (KSA) Biofabrication Market
8.7.2.1. Technology breakdown size & forecasts, 2025-2035
8.7.2.2. Material type breakdown size & forecasts, 2025-2035
8.7.2.3. Application breakdown size & forecasts, 2025-2035
8.7.3. South Africa Biofabrication Market
8.7.3.1. Technology breakdown size & forecasts, 2025-2035
8.7.3.2. Material type breakdown size & forecasts, 2025-2035
8.7.3.3. Application breakdown size & forecasts, 2025-2035

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Organovo Holdings, Inc.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Financial Performance (Subject to Data Availability)
9.2.5. Product/Services Port
9.2.6. Recent Development
9.2.7. Market Strategies
9.2.8. SWOT Analysis
9.3. CELLINK (BICO Group)
9.4. 3D Bioprinting Solutions
9.5. Cyfuse Biomedical K.K.
9.6. Aspect Biosystems
9.7. Allevi (now part of 3D Systems)
9.8. RegenHU Ltd.
9.9. InvivoSciences
9.10. BioBots (now part of 3D Systems)
9.11. Poietis
9.12. Advanced Solutions Life Sciences
9.13. EnvisionTEC (now part of Desktop Metal)
9.14. CollPlant Holdings Ltd.
9.15. BioFabUSA
9.16. Prellis Biologics

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Biofabrication Market, Report Scope
Table 2. Global Biofabrication Market Estimates & Forecasts By Region 2024–2035
Table 3. Global Biofabrication Market Estimates & Forecasts By Segment 2024–2035
Table 4. Global Biofabrication Market Estimates & Forecasts By Segment 2024–2035
Table 5. Global Biofabrication Market Estimates & Forecasts By Segment 2024–2035
Table 6. Global Biofabrication Market Estimates & Forecasts By Segment 2024–2035
Table 7. Global Biofabrication Market Estimates & Forecasts By Segment 2024–2035
Table 8. U.S. Biofabrication Market Estimates & Forecasts, 2024–2035
Table 9. Canada Biofabrication Market Estimates & Forecasts, 2024–2035
Table 10. UK Biofabrication Market Estimates & Forecasts, 2024–2035
Table 11. Germany Biofabrication Market Estimates & Forecasts, 2024–2035
Table 12. France Biofabrication Market Estimates & Forecasts, 2024–2035
Table 13. Spain Biofabrication Market Estimates & Forecasts, 2024–2035
Table 14. Italy Biofabrication Market Estimates & Forecasts, 2024–2035
Table 15. Rest Of Europe Biofabrication Market Estimates & Forecasts, 2024–2035
Table 16. China Biofabrication Market Estimates & Forecasts, 2024–2035
Table 17. India Biofabrication Market Estimates & Forecasts, 2024–2035
Table 18. Japan Biofabrication Market Estimates & Forecasts, 2024–2035
Table 19. Australia Biofabrication Market Estimates & Forecasts, 2024–2035
Table 20. South Korea Biofabrication Market Estimates & Forecasts, 2024–2035
………….